Preclinical pharmacokinetics, manufacturing, and safety studies supporting a multicenter cancer gene therapy trial.
Norman
J A
JA
Parker
S
S
Lew
D
D
Manthorpe
M
M
Marquet
M
M
D002986:Clinical Trials as Topic; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D004247:DNA; D004274:DNA, Recombinant; D015316:Genetic Therapy / Q000009:adverse effects; D015793:HLA-B7 Antigen / Q000096:biosynthesis / Q000235:genetics; D006801:Humans; D008055:Lipids / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D015337:Multicenter Studies as Topic; D009369:Neoplasms / Q000628:therapy*; D010957:Plasmids / Q000009:adverse effects / Q000235:genetics / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001613:beta 2-Microglobulin / Q000096:biosynthesis / Q000235:genetics
C096492:Allovectin-7; D004274:DNA, Recombinant; D015793:HLA-B7 Antigen; D008055:Lipids; D001613:beta 2-Microglobulin; D004247:DNA